ENANTA PHARMACEUTICALS INC Insider Trading for February 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ENANTA PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ENANTA PHARMACEUTICALS INC for February 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 13 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Payment of Exercise | F | 76.85 | 2,566 | 197,184 | 7,270 | 9.8 K to 7.3 K (-26.09 %) |
| Feb 13 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Grant | A | 0.00 | 6,028 | 0 | 9,836 | 3.8 K to 9.8 K (+158.30 %) |
| Feb 13 2018 | ENTA | ENANTA PHARMACEUTI ... | Adda Nathalie | Sr. VP & Chief Medi ... | Grant | A | 0.00 | 2,500 | 0 | 3,808 | 1.3 K to 3.8 K (+191.13 %) |
| Feb 13 2018 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Payment of Exercise | F | 76.85 | 2,065 | 158,685 | 12,327 | 14.4 K to 12.3 K (-14.35 %) |
| Feb 13 2018 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Grant | A | 0.00 | 4,822 | 0 | 14,392 | 9.6 K to 14.4 K (+50.39 %) |
| Feb 13 2018 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Grant | A | 0.00 | 2,000 | 0 | 9,570 | 7.6 K to 9.6 K (+26.42 %) |
| Feb 13 2018 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Payment of Exercise | F | 76.85 | 11,132 | 855,439 | 653,026 | 664.2 K to 653 K (-1.68 %) |
| Feb 13 2018 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Grant | A | 0.00 | 20,737 | 0 | 664,158 | 643.4 K to 664.2 K (+3.22 %) |
| Feb 13 2018 | ENTA | ENANTA PHARMACEUTI ... | Luly Jay R. | President and CEO | Grant | A | 0.00 | 8,600 | 0 | 643,421 | 634.8 K to 643.4 K (+1.35 %) |
| Feb 13 2018 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Payment of Exercise | F | 76.85 | 2,367 | 181,892 | 97,458 | 99.8 K to 97.5 K (-2.37 %) |
| Feb 13 2018 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Grant | A | 0.00 | 5,546 | 0 | 99,825 | 94.3 K to 99.8 K (+5.88 %) |
| Feb 13 2018 | ENTA | ENANTA PHARMACEUTI ... | MELLETT PAUL J | Treasurer and CFO | Grant | A | 0.00 | 2,300 | 0 | 94,279 | 92 K to 94.3 K (+2.50 %) |
| Feb 13 2018 | ENTA | ENANTA PHARMACEUTI ... | Ocain Tim | Senior Vice Preside ... | Payment of Exercise | F | 76.85 | 2,065 | 158,685 | 6,127 | 8.2 K to 6.1 K (-25.21 %) |
| Feb 13 2018 | ENTA | ENANTA PHARMACEUTI ... | Ocain Tim | Senior Vice Preside ... | Grant | A | 0.00 | 4,822 | 0 | 8,192 | 3.4 K to 8.2 K (+143.09 %) |
| Feb 13 2018 | ENTA | ENANTA PHARMACEUTI ... | Ocain Tim | Senior Vice Preside ... | Grant | A | 0.00 | 2,000 | 0 | 3,370 | 1.4 K to 3.4 K (+145.99 %) |
| Feb 13 2018 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Payment of Exercise | F | 76.85 | 2,666 | 204,869 | 309,920 | 312.6 K to 309.9 K (-0.85 %) |
| Feb 13 2018 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Grant | A | 0.00 | 6,269 | 0 | 312,586 | 306.3 K to 312.6 K (+2.05 %) |
| Feb 13 2018 | ENTA | ENANTA PHARMACEUTI ... | Or Yat Sun | Sr. VP & CSO | Grant | A | 0.00 | 2,600 | 0 | 306,317 | 303.7 K to 306.3 K (+0.86 %) |
| Feb 12 2018 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Option Exercise | M | 34.70 | 4,300 | 149,210 | 78,200 | |
| Feb 12 2018 | ENTA | ENANTA PHARMACEUTI ... | Gardiner Nathaniel S. | Sr. VP & General Co ... | Buy | M | 34.70 | 4,300 | 149,210 | 7,570 | 3.3 K to 7.6 K (+131.50 %) |